News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
328,867 Results
Type
Article (17830)
Company Profile (313)
Press Release (310716)
Multimedia
Podcasts (78)
Webinars (12)
Section
Business (95399)
Career Advice (216)
Deals (16803)
Drug Delivery (47)
Drug Development (57269)
Employer Resources (41)
FDA (6821)
Job Trends (6459)
News (171372)
Policy (11992)
Tag
Academia (996)
Accelerated approval (15)
Adcomms (14)
Allergies (77)
Alliances (24658)
ALS (129)
Alzheimer's disease (1130)
Antibody-drug conjugate (ADC) (233)
Approvals (7014)
Artificial intelligence (260)
Autoimmune disease (103)
Automation (10)
Bankruptcy (121)
Best Places to Work (5559)
BIOSECURE Act (7)
Biosimilars (118)
Biotechnology (239)
Bladder cancer (104)
Brain cancer (44)
Breast cancer (370)
Cancer (3285)
Cardiovascular disease (252)
Career advice (198)
Career pathing (9)
CAR-T (231)
CDC (6)
Cell therapy (595)
Cervical cancer (18)
Clinical research (49132)
Collaboration (1093)
Company closure (3)
Compensation (672)
Complete response letters (35)
COVID-19 (1232)
CRISPR (84)
C-suite (518)
Cystic fibrosis (123)
Data (4472)
Decentralized trials (1)
Denatured (13)
Depression (88)
Diabetes (271)
Diagnostics (2091)
Digital health (12)
Diversity (6)
Diversity, equity & inclusion (10)
Drug discovery (178)
Drug pricing (53)
Drug shortages (5)
Duchenne muscular dystrophy (205)
Earnings (40347)
Editorial (25)
Employer branding (8)
Employer resources (38)
Events (60520)
Executive appointments (662)
FDA (8591)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (20)
Funding (977)
Gene editing (182)
Generative AI (22)
Gene therapy (483)
GLP-1 (606)
Government (1292)
Grass and pollen (3)
Guidances (219)
Healthcare (7737)
HIV (26)
Huntington's disease (40)
IgA nephropathy (76)
Immunology and inflammation (204)
Immuno-oncology (26)
Indications (53)
Infectious disease (1366)
Inflammatory bowel disease (154)
Inflation Reduction Act (10)
Influenza (47)
Intellectual property (161)
Interviews (23)
IPO (9032)
IRA (21)
Job creations (1229)
Job search strategy (175)
Kidney cancer (9)
Labor market (27)
Layoffs (360)
Leadership (13)
Legal (1732)
Liver cancer (55)
Longevity (9)
Lung cancer (458)
Lymphoma (279)
Machine learning (25)
Management (11)
Manufacturing (379)
MASH (138)
Medical device (3216)
Medtech (3231)
Mergers & acquisitions (8442)
Metabolic disorders (785)
Multiple sclerosis (113)
NASH (14)
Neurodegenerative disease (228)
Neuropsychiatric disorders (71)
Neuroscience (2028)
NextGen: Class of 2025 (2322)
Non-profit (983)
Now hiring (28)
Obesity (363)
Opinion (151)
Ovarian cancer (134)
Pain (99)
Pancreatic cancer (147)
Parkinson's disease (216)
Partnered (14)
Patents (315)
Patient recruitment (296)
Peanut (43)
People (30385)
Pharmaceutical (50)
Pharmacy benefit managers (8)
Phase I (16971)
Phase II (22677)
Phase III (14985)
Pipeline (2907)
Policy (101)
Postmarket research (960)
Preclinical (7055)
Press Release (32)
Prostate cancer (149)
Psychedelics (48)
Radiopharmaceuticals (257)
Rare diseases (608)
Real estate (1782)
Recruiting (17)
Regulatory (11348)
Reports (20)
Research institute (1052)
Resumes & cover letters (25)
Rett syndrome (21)
RNA editing (16)
RSV (32)
Schizophrenia (126)
Series A (176)
Series B (127)
Service/supplier (2)
Sickle cell disease (85)
Special edition (17)
Spinal muscular atrophy (124)
Sponsored (16)
Startups (2232)
State (1)
Stomach cancer (5)
Supply chain (37)
Tariffs (25)
The Weekly (64)
Vaccines (459)
Venture capital (61)
Weight loss (210)
Women's health (36)
Worklife (2)
Date
Today (63)
Last 7 days (394)
Last 30 days (1615)
Last 365 days (21220)
2025 (20639)
2024 (23715)
2023 (26007)
2022 (31456)
2021 (32380)
2020 (27256)
2019 (19206)
2018 (14147)
2017 (16684)
2016 (14150)
2015 (17049)
2014 (12164)
2013 (8702)
2012 (8919)
2011 (9166)
2010 (8903)
Location
Africa (202)
Alabama (66)
Alaska (2)
Arizona (73)
Arkansas (5)
Asia (21704)
Australia (3732)
California (7564)
Canada (1941)
China (784)
Colorado (239)
Connecticut (294)
Delaware (239)
Europe (47547)
Florida (915)
Georgia (228)
Hawaii (2)
Idaho (19)
Illinois (400)
India (34)
Indiana (208)
Iowa (9)
Japan (260)
Kansas (80)
Kentucky (9)
Louisiana (8)
Maine (11)
Maryland (831)
Massachusetts (5876)
Michigan (113)
Minnesota (247)
Mississippi (3)
Missouri (42)
Montana (17)
Nebraska (4)
Nevada (39)
New Hampshire (18)
New Jersey (1954)
New Mexico (15)
New York (1929)
North Carolina (860)
North Dakota (6)
Northern California (3740)
Ohio (179)
Oklahoma (13)
Oregon (23)
Pennsylvania (1314)
Puerto Rico (10)
Rhode Island (26)
South America (275)
South Carolina (12)
Southern California (2904)
Tennessee (47)
Texas (984)
United States (25041)
Utah (121)
Virginia (154)
Washington D.C. (43)
Washington State (595)
West Virginia (1)
Wisconsin (68)
Wyoming (1)
328,867 Results for "pipeline therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Funding
Artios Pushes Cancer Pipeline Forward With $115M Series D
Artios Pharma is working on a pipeline of oncology assets, led by alnodesertib, currently being tested for second-line pancreatic cancer and third-line colorectal cancer.
November 17, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results
November 14, 2025
·
17 min read
Press Releases
Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2025 Financial Results
November 10, 2025
·
12 min read
Press Releases
Aardvark Therapeutics to Present Data on Pipeline Programs at Upcoming ObesityWeek
October 23, 2025
·
5 min read
Press Releases
Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress
November 10, 2025
·
14 min read
Press Releases
Newleos Therapeutics Announces Clinical Progress Across Neuropsychiatric Pipeline
October 1, 2025
·
6 min read
Press Releases
Aardvark Therapeutics Reports Third Quarter 2025 Financial Results and Provides Pipeline and Business Updates
November 14, 2025
·
10 min read
Press Releases
Aardvark Therapeutics Presents Data Supporting its Metabolic Obesity Pipeline Programs at ObesityWeek 2025
November 5, 2025
·
9 min read
Press Releases
Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline
October 22, 2025
·
11 min read
Press Releases
Merck Data to be Presented at ASH 2025 Annual Meeting Showcase Continued Advancements in Hematology Pipeline and Novel Therapeutic Approaches
November 24, 2025
·
10 min read
1 of 32,887
Next
